Ashton Thomas Private Wealth LLC Acquires New Shares in SIGA Technologies, Inc. (NASDAQ:SIGA)

Ashton Thomas Private Wealth LLC acquired a new stake in SIGA Technologies, Inc. (NASDAQ:SIGA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 70,292 shares of the company’s stock, valued at approximately $422,000. Ashton Thomas Private Wealth LLC owned about 0.10% of SIGA Technologies at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of SIGA. Hotchkis & Wiley Capital Management LLC lifted its stake in shares of SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after purchasing an additional 1,237,620 shares during the last quarter. Foundry Partners LLC acquired a new stake in shares of SIGA Technologies in the 3rd quarter valued at $2,801,000. Denali Advisors LLC lifted its stake in shares of SIGA Technologies by 58.3% in the 4th quarter. Denali Advisors LLC now owns 378,544 shares of the company’s stock valued at $2,275,000 after purchasing an additional 139,354 shares during the last quarter. Wellington Management Group LLP acquired a new stake in shares of SIGA Technologies in the 3rd quarter valued at $757,000. Finally, Bank of New York Mellon Corp lifted its stake in shares of SIGA Technologies by 52.4% in the 4th quarter. Bank of New York Mellon Corp now owns 289,712 shares of the company’s stock valued at $1,741,000 after purchasing an additional 99,670 shares during the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Price Performance

SIGA Technologies stock opened at $5.71 on Tuesday. The firm has a market cap of $407.72 million, a price-to-earnings ratio of 4.76 and a beta of 0.98. SIGA Technologies, Inc. has a fifty-two week low of $4.75 and a fifty-two week high of $12.83. The firm has a fifty day moving average price of $6.01 and a two-hundred day moving average price of $6.73.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.